Paper12640685
Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
Hemminki K and 2 others. Int J Cancer, 2003. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites. Papers, record 12640685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12640685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Predisposition to Disease | Major topic |
| Melanoma | Major topic |
| Neoplasm Invasiveness | Major topic |
| Skin Neoplasms | Major topic |
| Sunlight | Major topic |
| Adolescent | |
| Adult | |
| Age Distribution | |
| Aged | |
| Aged, 80 and over | |
| Child | |
| Family Health | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Registries | |
| Risk Factors | |
| Sweden |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41854120 | International Dermoscopy Society consensus recommendations for the management of lentigo maligna. | J Eur Acad Dermatol Venereol | 2026 | https://conductscience.org/library/papers/41854120 | PubMed |
| 32926174 | Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma. | Acta Derm Venereol | 2020 | https://conductscience.org/library/papers/32926174 | PubMed |
| 29946532 | Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment. | Front Oncol | 2018 | https://conductscience.org/library/papers/29946532 | PubMed |
| 25526608 | Interventions for melanoma in situ, including lentigo maligna. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25526608 | PubMed |
| 23579556 | Host risk factors, ultraviolet index of residence, and incident malignant melanoma in situ among US women and men. | Am J Epidemiol | 2013 | https://conductscience.org/library/papers/23579556 | PubMed |
| 17533392 | Melanoma incidence and mortality in Scotland 1979-2003. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17533392 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12640685
GET https://conductscience.org/api/papers/v1/12640685/authors